Blog
  by

In the News: December 8-14

Sg2 is dedicated to helping our clients interpret the latest news and trends in health care. Below you’ll find our analysis of this week’s key industry headlines, along with links to related Sg2 resources.

CMS Posts Updated Medicare Outpatient Observation Notice Form

In preparation for the March 8, 2017, implementation deadline of the Notice of Observation Treatment and Implication for Care Eligibility Act (NOTICE Act), CMS has released downloadable copies of the Medicare Outpatient Observation Notice (MOON) on its website. The NOTICE Act requires all hospitals to provide written (MOON) and oral notification of observation status to Medicare patients who receive outpatient observation services for more than 24 hours. Patients must receive an explanation of the cost-sharing implications of outpatient status and their subsequent eligibility for skilled nursing facility care.

Are your observation services enabling clinically valuable, cost-effective, short-term intensive treatment? Learn more about initiatives to improve observation care, including a case study from a leading organization in the field, by reading the Sg2 Performance Guide: Optimizing Observation Care.


AHRQ Reports Sizable Reduction in Hospital-Acquired Conditions

Based on initial findings of the Agency for Healthcare and Research Quality’s National Scorecard for 2015, US hospitals achieved a 21% reduction in hospital-acquired conditions (HACs) from 2010 to 2015. This achievement translates into 125,000 fewer patient deaths associated with HACs, as well as a cost savings of $28B.

Although there is not a single direct cause for these findings, hospitals and programs have employed various levers in their quality improvement efforts to standardize operations and reduce risk of falls and hospital-acquired infections. To learn more about the latest evolution of various CMS performance-based programs, watch Sg2’s payment update webinar.


Newly Signed Cures Act Provides Funds for Cancer Moonshot and Precision Medicine

President Obama has signed the 21st Century Cures Act into law. This law is a complex amalgamation of initiatives that directs over $6B in health care spending. Included among the provisions are over $3B to support the “Beau Biden Cancer Moonshot” and the “Precision Medicine Initiative.”

Sg2 has been closely monitoring technological innovations shaping the precision medicine landscape in cancer care. The emphasis has moved from simply collecting clinical data to integrating, aggregating, and synthesizing multiple types of data to ultimately advance care for cancer patients. To learn more, read this Expert Insight from Sg2 Expert Tim Remus.

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube